Uses for amino acid anticonvulsants

Details Uses for amino acid anticonvulsants Uses for amino acid anticonvulsants

2007-03-06

2007-03-06

Lukton, David (Department: 1654)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carboxylic acids and salts thereof

C562S567000, C562S575000, C514S018700, C514S019300, C530S331000

Reexamination Certificate

active

10688709

ABSTRACT:
The present invention is directed to the use of compounds of the formula:for treating pain, in particular neuropathic pain, bipolar disease and migraine headaches.

REFERENCES:
patent: 5331089 (1994-07-01), Curtis et al.
patent: 5378729 (1995-01-01), Kohn et al.
patent: 5654301 (1997-08-01), Kohn et al.
patent: 5696116 (1997-12-01), Clozel et al.
patent: 5773475 (1998-06-01), Kohn
patent: 5885999 (1999-03-01), Elliot et al.
patent: 6096712 (2000-08-01), Szelke et al.
patent: 6133261 (2000-10-01), Harris
patent: 6228875 (2001-05-01), Tsai et al.
patent: 6368788 (2002-04-01), Kozhemyakin et al.
patent: 6716810 (2004-04-01), Brennan et al.
patent: 6803481 (2004-10-01), Selve
patent: 0 997147 (1998-07-01), None
patent: 1 084 704 (2001-03-01), None
patent: WO 99/03460 (1999-01-01), None
patent: WO 99/43309 (1999-09-01), None
patent: 98/5940 (1998-07-01), None
Goldstein, D. J. (Cephalalgia : an International Journal of Headache 17 (7) 785-90, 1997).
Brandes, Jan L (Headache 44 (6) 581-6, 2004).
Kohn H. et al., “Synthesis and anticonvulsant activities of α-heterocyclic α-acetamido-N-benzylacetamide derivatives”,Journal of Medicinal Chemistry, United States Oct. 29, 1993, vol. 36, No. 22, pp. 3350-3360.
Andurkar, et al., “The Anticonvulsant Activities of N-Benzyl 3-Methoxypropionamides”, Bioorganic & Medicinal Chemistry 7 (1999), pp. 2381-2389.
Toniolo, et al., “A crystal-state, solution and theoretical study of the preferred conformation of linear C.α,α-diphenylglycine derivatives and dipeptides with potential anticonvulsant activity”,Int. J. Pept. Protein Res. 44. 1994, 85-95, XP001074241, , p. 85, col. 1, paragraph 2, p. 86, col. 1; example XIV.
Billich, et al., “HIV proteinase inhibitors containing 2-aminobenzylstatine as a novel scissile bond replacement: biochemical. and pharmacological characterization”,Antiviral Research 25(1994) pp. 215-233.
Parsons, et al., “Modulation of NMDA receptors by glycine—introduction to some basic aspects and recent developments”,Amino Acids, 14:207-216 (1998).
Wlaz, et al., “Anticonvulsant effects of eliprodil alone or combined with the glycineβreceptor antagonist L-701,324 or the competitive NMDA antagonist CGP 40116 in the amygdala kindling model in rats”,Neuropharmacology, 38:243-251 (1999).
Ebert, et al., “Anticonvulsant effects by combined treatment with a glycineβreceptor antagonist and a polyamine site antagonist in the amygdala-kindled rats”,European Journal of Pharmacology, 322:179-184 (1997).
Kohn H. et al., “Synthesis and anticonvulsant activities of α-heterocyclic α-acetamido-N-benzylacetamide derivatives”,Journal of Medicinal Chemistry, United States Oct. 29, 1993, vol. 36, No. 22, pp. 3350-3360, ISSN: 0022-2623, p. 3355, col. 1, paragraph 2, example 3F; table 1.
Shridhar V. Andurkar, et al., “The Anticonvulsant Activities of N-Benzyl 3-Methoxypropionamides”, Bioorganic & Medicinal Chemistry 7 (1999), pp. 2381-2389, p. 2381, col. 2; example 3, p. 2385, col. 1, paragraph 2-paragraph 3, XP001097157.
Claudio Toniolo, et al., “A crystal-state, solution and theoretical study of the preferred conformation of linear C.α,α-diphenylglycine derivatives and dipeptides with potential anticonvulsant activity”,Int. J. Pept. Protein Res. 44. 1994, 85-95, XP001074241, , p. 85, col. 1, paragraph 2, p. 86, col. 1; example XIV.
Angreas Billich, et al., “HIV proteinase inhibitors containing 2-aminobenzylstatine as a novel scissile bond replacement: biochemical. and pharmacological characterization”,Antiviral Research 25(1994) pp. 215-233, XP008006766, p. 216; table 1.
Solomon H. Snyder, et al., D-Amino Acids as Putative Neurotransmitters: Focus on D-Serine,Neurochemical Research, vol. 25, No. 5, 2000, pp. 553-560.
Myung Ha Yoon, MD, et al., The effect of Intrathecal Gabapentin on Pain Behaivor and Hemodynamics on the Formalin Test in the Rat,International Anesthesia Research Society, (1999), pp. 434-439.
David E. Baranano, et al., “Atypical neural messengers”,TRENDS in Neurosciences, vol. 24, No. 2, Feb. 2001, pp. 99-106.
J.M. Elliott, et al., “Serine Derived NK1Antagonists 1: The Effect of Modifications to the Serine Substituents”,Bioorganic&Medicinal Chimistry Letters 8(1998) pp. 1845-1850.
Solomon H. Snyder, M.D., et al., “Novel Neurotransmitters and their Neuropsychiatric Relevance”,Am J Psychiatry, 157:11, Nov. 2000, pp. 1738-1751.
Robert Berkow, M.D., et al., “The Merck Manual of Diagnosis and Therapy”,Merck Research Laboratories, (1992), pp. 1406-1615 .
Harris FRC, and Schwarz Pharma AG,Windover Information Inc., 2000, p. 122.
Herman Wolosker, et al., “Serine racemase: A glial enzyme synthesizing D-serine to regulate glutamate-N-methyl-D-asparatate neurotransmission”,PNAS, vol. 96, No. 23, Nov. 9, 1999, pp. 13409-13414.
Fu Y, et al., Systemic nicotine stimulates dopamine release in nucleus accumbens: Reevaluation of the role of N-methyl-D-aspartate receptors in the ventral tegmental area [In Process Citation],J Pharmacol Exp Ther 2000, Aug.;294(2):458-65.
Daeock Choi, “Synthesis, Chemistry, and Biological Evaluation of Medicinally Relevant Compounds”,A Bell&Howell Company, Dec. 1995, pp. 1-208.
Abstract of International Application No. WO 99/02146 dated Jan. 21, 1999.

Affiliated with

Also associated with

Rating

Uses for amino acid anticonvulsants does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Uses for amino acid anticonvulsants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Uses for amino acid anticonvulsants will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3723423